🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Tablet(s) Serving Size
30 Servings
Mineral Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
Sugar
1.5 Gram(s)
Calcium
400 mg (40% DV)
2 mg (1% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 2mg

Other Ingredients

Adipic Acid Blue 1 Dextrose Flavors Magnesium Stearate Maltodextrin Red 27 Starch Sucralose Yellow 6 Yellow 10

Label Claims — Verification

Nutrient
All Other
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years) Kosher

Product Information

📋 Directions for Use

Driections Chew 2-4 tablets as symptoms occur, or as directed by a doctor.

Peal back here Read entire label including drug facts and allergy warnings.

Directions: Chew 2 tablets once or twice daily with a meal.

⚠️ Warnings & Precautions

Warnings Ask a doctor or pharmacist before use if you are taking a prescription drug. Antacids may interact with certain prescription drugs.

When using this product Do not take more than 15 tablets in 24 hours Do not use the maximum dosage for more than 2 weeks

Keep out of reach of children.

Safety sealed: Do not use if printed seal under cap is torn or missing

🧪 Formulation Notes

Calcium rich

K Parve

For calcium and magnesium content see Supplement Facts.

Uses: As a daily source of extra calcium.

Additional Information

Compare to Tums Active Ingredient NDC-68163-101-12 Regular strength

Relieves: Acid Indigestion Sour stomach Heartburn

Assorted Fruit Naturally & artificially flavored Chewable tablets

K Parve

Uses relieves: Heartburn Sour stomach Acid indigestion Upset stomach associated with these symptoms

101AF60DCLF

This product is not manufactured or distributed by GlaxoSmithKline, the distributor of TUMS

Other Information Store below 30(0)C (86(0)F) Keep container tightly closed

Product Details

UPC / SKU 3 68163 10162 1
DSLD Entry Date 2019-08-23
Product Type Mineral
Form Tablet or Pill
Brand Dr Choice
DSLD ID 206178
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →